Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Regulatory

Regulatory  ·  Weekly Digest 21 Dec to 27 Dec 2024
DATROWAY® approved in Japan as the first TROP-2 directed therapy for patients with previously treated unresectable or recurrent HR positive, HER2 negative breast cancer

Weekly Digest – December 2024 Weekly Digest – December 2024 27 Dec 2024: DATROWAY® approved in Japan as the first TROP-2 directed therapy for patients with previously treated unresectable or recurrent HR positive, HER2 negative breast cancer Daiichi Sankyo’s DATROWAY® […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 21 Dec to 27 Dec 2024
IND application for a phase I/II clinical study of anti-HER2 bispecific ADC subcutaneous co-formulation JSKN033 was approved

Weekly Digest – December 2024 Weekly Digest – December 2024 26 Dec 2024: IND application for a phase I/II clinical study of anti-HER2 bispecific ADC subcutaneous co-formulation JSKN033 was approved Alphamab Oncology has received approval from the CDE of the […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 21 Dec to 27 Dec 2024
Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn

Weekly Digest – December 2024 Weekly Digest – December 2024 24 Dec 2024: Datopotamab deruxtecan application in the EU for patients with advanced nonsquamous non-small cell lung cancer voluntarily withdrawn AstraZeneca and Daiichi Sankyo have voluntarily withdrawn their marketing authorization […]

by Sandhya Ramalingam

Continue Reading


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id